Membrane Shedding During Severe Sepsis and Septic Shock: Pathophysiological and Clinical Relevance
NCT02391792 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2016-08-24
Summary
Microparticules (MPs) result from plasma cell membrane remodeling and shedding after cell stimulation or apoptosis. MPs are know recognized as a pool of bioactive messengers with merging role in pathophysiology of immune and cardiovascular diseases. MPs have been characterized during septic shock and may contribute to dissemination of pro-inflammatory and procoagulant mediators. This a prospective observational study of circulating MPs and blood coagulation in septic shock patients admitted in medical intensive care units (ICUs) of four tertiary hospitals at baseline (D1, D2, D3, D4, D7).
Conditions
- Severe Sepsis and Septic Shock
Sponsors & Collaborators
-
University Hospital, Strasbourg, France
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-03-31
- Primary Completion
- 2020-03-31
- Completion
- 2020-03-31
Countries
- France
Study Locations
More Related Trials
-
Following of Myeloid-derived Suppressor Cells (MDSC) in Severe Sepsis: What Relationship With Systemic Inflammatory Syndrome?
NCT02903082 ·Status: TERMINATED
-
Metabolic Cluster Analysis in Septic Shock Patients
NCT06500156 ·Status: RECRUITING
-
Pro-inflammatory Role of Blood Platelets in Critically Ill Patients With Septic Shock.
NCT04080453 ·Status: COMPLETED
-
Skeletal Muscle and Platelet Mitochondrial Dysfunction During Sepsis
NCT00541827 ·Status: COMPLETED
-
Bio-clinical Evolutive Dynamic in Patients Suffering From Communitary Septic Shock (Biosepsis)
NCT01668329 ·Status: COMPLETED
-
PLatelets Acetyl-CoA Carboxylase Phosphorylation State in SEPtic Shock
NCT04107402 ·Status: COMPLETED ·Phase: NA
-
Monitoring Mitophagy In Myeloid Cells Upon Intensive Care
NCT05040503 ·Status: COMPLETED ·Phase: NA
-
Impact of Vascular Calcification and CASR Expression by Monocytes in Septic Shock
NCT06853340 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Hemodynamic Effects of Cascade Hemofiltration in Septic Shock
NCT00922870 ·Status: COMPLETED ·Phase: NA
-
Evolution of Muscle Function, Breathlessness and Quality of Life Following Intra or Extra-Abdominal Sepsis in ICU Patients
NCT06010186 ·Status: RECRUITING ·Phase: NA
-
INFLAmmasomes NLRP3 in Platelets and Leukocytes During SEPSIS in Intensive Care Unit
NCT04635878 ·Status: COMPLETED
-
Cytokine Adsorption in Severe, Refractory Septic Shock
NCT04910893 ·Status: COMPLETED ·Phase: NA
-
Interstitial Fluid Composition in Patients With Septic Versus Non-septic Shock: an Exploratory Pilot Study
NCT05039151 ·Status: COMPLETED
-
Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)
NCT02803346 ·Status: UNKNOWN
-
Change in MAPSE During Treatment of Sepsis
NCT05634733 ·Status: RECRUITING
-
Characterization of Hemostatic Disordres in Septic Shock: Searching for Biological Markers
NCT02692053 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Prognostic Value of Immature Platelet Fraction
NCT07039227 ·Status: COMPLETED
-
Septic Shock-induced Immunosuppression
NCT04067674 ·Status: RECRUITING
-
Monitoring Resuscitation in Severe Sepsis and Septic Shock
NCT01747057 ·Status: UNKNOWN ·Phase: NA
-
REmote Ischemic COnditioning in Septic Shock
NCT03201575 ·Status: COMPLETED ·Phase: NA
-
Safety, Pharmacokinetics and Pharmacodynamics of BMS-936559 in Severe Sepsis
NCT02576457 ·Status: TERMINATED ·Phase: PHASE1
-
Activated Protein C and Corticosteroids for Human Septic Shock
NCT00625209 ·Status: COMPLETED ·Phase: PHASE3
-
Pediatric Immune Response to Infectious Shock
NCT02848144 ·Status: COMPLETED ·Phase: NA
-
Early Albumin Resuscitation During Septic Shock
NCT00327704 ·Status: COMPLETED ·Phase: PHASE4
-
Use of Fc-MBL to Detect and Monitor the Presence of PAMPs During Septic Shock
NCT03457038 ·Status: UNKNOWN ·Phase: NA